Jupiter Neurosciences Files 8-K
Ticker: JUNS · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1679628
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
JUPITER NEUROSCIENCES FILED AN 8-K, DETAILS UNCLEAR FROM THIS SNIPPET.
AI Summary
Jupiter Neurosciences, Inc. filed an 8-K on July 10, 2025, reporting other events and financial statements and exhibits. The filing does not contain specific financial figures or details about the 'other events' in the provided text.
Why It Matters
This filing indicates Jupiter Neurosciences is making a regulatory submission, but the specific details of the 'other events' are not yet disclosed in the provided text.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events, and the provided text does not contain information suggesting significant risk.
Key Players & Entities
- JUPITER NEUROSCIENCES, INC. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Jupiter Orphan Therapeutics, Inc. (company) — Former company name
FAQ
What specific 'Other Events' are being reported by Jupiter Neurosciences?
The provided text of the 8-K filing does not specify the details of the 'Other Events'.
When was the report filed with the SEC?
The report was filed on July 10, 2025.
What is the principal executive office address for Jupiter Neurosciences?
The principal executive office is located at 1001 North US HWY 1, Suite 504, Jupiter, FL 33477.
What is the SIC code for Jupiter Neurosciences?
The Standard Industrial Classification (SIC) code is 2834 for Pharmaceutical Preparations.
Has Jupiter Neurosciences changed its name previously?
Yes, the company was formerly known as Jupiter Orphan Therapeutics, Inc., with a name change date of July 13, 2016.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding JUPITER NEUROSCIENCES, INC. (JUNS).